
Press Releases
NRG1 Fusion-Targeted Therapy Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036
In a pivotal moment for precision medicine, the NRG1 fusion-targeted therapy market is emerging as a beacon of hope for patients battling rare, genetically driven cancers. As